What Is THC? Effects, Risks, and Why It Can Be Addictive

Cannabis is legal across Canada, but legality hasn't stripped THC of its ability to reshape the brain with repeated use. Tetrahydrocannabinol is the compound behind the high, and for a significant share of regular users it also opens the door to dependence. This article breaks down what THC does inside the body, how dependence develops, and when use crosses a line that calls for professional help.

You Will Learn

• What THC is at the molecular level and how it interacts with the brain's endocannabinoid system
• The short-term and long-term effects of THC on cognition, mood, and physical health
• How tolerance and dependence develop and why roughly one in five regular users meets the criteria for cannabis use disorder
• Which side effects signal that use has become a clinical problem
• What treatment and recovery look like when cannabis use disorder takes hold

What Is THC?

THC stands for tetrahydrocannabinol, a naturally occurring chemical compound classified as a cannabinoid. It is the primary psychoactive ingredient in the cannabis plant and the molecule responsible for the intoxicating effects that most people associate with marijuana use.

The most studied and abundant form is delta-9-tetrahydrocannabinol, often written as delta-9-THC. This is the compound produced in the resin glands of the cannabis flower and the one used to label and regulate Canadian cannabis products under the Cannabis Act. Other variants exist, including delta-8-THC, which occurs in trace amounts and produces milder psychoactive effects, and tetrahydrocannabinolic acid (THCA), the raw acidic precursor that converts to active THC when heated through smoking, vaporising, or cooking¹.

Rising Potency

The potency of THC in commercially available cannabis has climbed sharply over the past two decades. Average THC potency has increased three- to fivefold, and that shift carries direct implications for dependence risk, cognitive side effects, and the severity of withdrawal when a heavy user stops².

How THC Works in the Brain

THC acts on the body's endocannabinoid system (ECS), a network of receptors and signalling molecules that regulates pain, mood, appetite, sleep, and memory. The system relies on naturally produced compounds called endocannabinoids, with anandamide being the most well known. Under normal conditions, endocannabinoids bind to cannabinoid-1 (CB1) receptors in precise, short-lived bursts that fine-tune neural activity across the brain³.

THC mimics the shape of these endocannabinoids closely enough to latch onto the same CB1 receptors, but it behaves differently once it gets there. Anandamide arrives briefly and degrades quickly. THC saturates the receptor sites and stays.

Dopamine and the Reward Circuit

That prolonged CB1 activation triggers a surge of dopamine release in the nucleus accumbens, the brain's primary reward centre. THC pushes neurons in the reward system to release dopamine at levels higher than those triggered by natural rewarding stimuli, and the resulting dopamine flood teaches the brain to repeat the behaviour⁴.

This is the same reward-circuit disruption that occurs with other substances of misuse. Cannabis simply moves through the process at a pace that makes it harder to notice, which is why dependence can take root before the user registers what has changed.

Tolerance and Downregulation

CB1 receptors are concentrated in the prefrontal cortex, hippocampus, cerebellum, and basal ganglia, all of which play central roles in decision-making, memory formation, motor coordination, and emotional regulation⁵. When THC activates these receptors repeatedly, the brain compensates by reducing both the number and sensitivity of CB1 receptors, a process called downregulation. That downregulation is the biological foundation of tolerance, and tolerance is what opens the path to dependence.

THC Effects, Short-Term and Long-Term

The effects a person experiences depend on the dose, the method of consumption, their tolerance level, and individual biology. A single use and years of daily use produce very different clinical pictures.

Short-Term Effects

A dose delivered through smoking or vaporising typically takes effect within minutes. Edibles can take one to two hours because the compound passes through the digestive system and liver before reaching the brain. During this first-pass metabolism, the liver converts THC into 11-hydroxy-THC, a metabolite that crosses the blood-brain barrier more efficiently and produces a more potent, longer-lasting high. Regardless of delivery method, the acute effects follow a consistent pattern¹.

• Euphoria and altered sensory perception
• Impaired short-term memory and concentration
• Slowed reaction time and compromised motor coordination
• Increased heart rate (tachycardia), which can spike 20 to 50 beats per minute above baseline
• Heightened appetite
• Anxiety, paranoia, or panic in some users, particularly at higher doses

These effects are generally self-limiting and resolve within a few hours. The cardiovascular spike, though, poses a real risk for people with underlying heart conditions, and acute anxiety episodes can be severe enough to send someone to the emergency department.

Long-Term Effects

Chronic, heavy use looks very different. Research consistently links prolonged THC exposure to measurable changes in brain structure and function, particularly when use begins during adolescence while the brain is still developing⁵.

People who begin using cannabis in their teens face an estimated four to seven times higher risk of developing cannabis use disorder compared to those who start as adults⁴.

THC Side Effects and the Path to Dependence

The conversation around side effects often stays limited to dry mouth, red eyes, and short-term memory fog. Those are real, but they obscure the larger clinical concern, which is the capacity for dependence that regular THC use creates.

How Common Is Cannabis Use Disorder?

Cannabis use disorder (CUD) is a recognised diagnosis in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). According to the Centers for Disease Control and Prevention, an estimated 30 percent of people who use cannabis will develop some degree of the disorder⁶. Among daily or near-daily users, the rates climb higher still. The 2023 National Survey on Drug Use and Health found that approximately 6.8 percent of Americans aged 12 and older, roughly 19.2 million people, met the criteria for past-year marijuana use disorder, with rates substantially elevated among young adults². Canadian data follows a similar trajectory, with cannabis use rates among young adults consistently ranking among the highest in the world since legalisation in 2018.

What Withdrawal Looks Like

The withdrawal profile reinforces that this is a physiological process, not simply a matter of habit. Cannabis withdrawal symptoms emerge within 24 hours of cessation and can persist for one to two weeks. They include irritability, anxiety, insomnia, loss of appetite, sweating, nausea, depressed mood, and intense cravings⁷. Nearly half of regular users in treatment report experiencing withdrawal, and disrupted sleep is the symptom most commonly linked to relapse⁸.

As THC potency has risen and daily use has become more normalised, the clinical presentation of cannabis withdrawal has grown more severe. The gap between cannabis dependence and the dependence profiles seen with alcohol or benzodiazepines has been closing.

For anyone curious about what the physical clearance process involves, the guide on how a THC detox kit works explains the timeline and the body's elimination pathways in detail.

THC Dose, Potency, and Risk

There is no universally agreed-upon safe dose, but the clinical literature offers useful thresholds. For someone with no tolerance, as little as 3 to 5 milligrams of THC is enough to produce intoxication. Amounts above 10 milligrams are generally considered high for infrequent users¹.

Today's cannabis products routinely deliver THC concentrations that bear little resemblance to the plant material available a generation ago. Concentrates can exceed 80 percent THC. Even standard flower in Canadian dispensaries commonly sits between 15 and 30 percent. Higher potency means more CB1 receptor activation per session, faster tolerance development, and a steeper withdrawal curve when use stops².

Why Edibles Carry Extra Risk

Edible cannabis products, including the growing market for THC-infused drinks, carry an additional risk layer. Because onset is delayed by 60 to 120 minutes, users frequently consume more than intended before the first dose has taken full effect. The liver's conversion of delta-9-THC into 11-hydroxy-THC during first-pass metabolism makes the experience substantially more potent than the same milligram amount consumed through inhalation. 11-hydroxy-THC crosses the blood-brain barrier more efficiently than delta-9-THC, which is why edibles can produce effects that feel disproportionately strong relative to the labelled dose. This pharmacokinetic difference accounts for the majority of cannabis-related emergency department visits tied to overconsumption¹.

When THC Use Becomes a Problem Worth Treating

Cannabis use disorder does not arrive as a single dramatic event. It builds through patterns that the user often rationalises. Needing more to feel the same effect. Spending increasing amounts of time obtaining or using cannabis. Continuing despite clear consequences at work or in relationships. Experiencing withdrawal symptoms whenever use stops².

Diagnostic Criteria

The DSM-5 outlines 11 diagnostic criteria for cannabis use disorder. Meeting two or three criteria places the diagnosis in the mild range, four or five in moderate, and six or more in severe. For someone in the severe category, the clinical picture often includes failed attempts to quit, neglected responsibilities, social withdrawal, and physical dependence that makes abstinence acutely uncomfortable.

How Treatment Works

No medication is currently approved to treat cannabis use disorder specifically². Psychosocial interventions remain the first-line approaches, including cognitive behavioural therapy (CBT), motivational enhancement therapy, and contingency management. CBT helps the person identify the situations and thought patterns that trigger use, while motivational enhancement therapy works on strengthening the internal reasons for change. Medical support during withdrawal can address the insomnia, anxiety, and appetite disruption that drive early relapse.

At the Canadian Centre for Addictions, the clinical team works across medically supervised detox, individual and group counselling, and structured post-treatment planning. Three physicians and round-the-clock nursing staff operate from two residential properties in Ontario, and the programs are built to address the full clinical profile of each client, whether the primary substance is cannabis, alcohol, opioids, or a combination.

Concerned about your cannabis use or someone else's?

The Canadian Centre for Addictions offers medically supervised detox and individualised residential treatment at its Ontario locations. Call 1-855-499-9446 for a free, confidential conversation about the safest way forward.

FAQ